Skip to main content

Excess Antibiotic Duration for Adult Hospitalized Patients with Uncomplicated Community-Acquired Pneumonia

CBE ID
4540e
Endorsement Status
E&M Committee Rationale/Justification

When the measure returns for maintenance (3 years), the measure developer should have:

  • Continued to explore the exclusion list to determine if changes are needed (e.g., empirical analyses with broader testing across entities) and to further clarify the conditions and justify them based on burden; and
  • Conducted additional validity testing (data element in additional EHR).
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
Next Maintenance Cycle
Fall 2027
1.6 Measure Description

The Excess Antibiotic Duration for Adult Hospitalized Patients with Uncomplicated Community-Acquired Pneumonia measure is a process measure representing the annual percentage of hospitalized adults with uncomplicated community-acquired pneumonia who receive an excess antibiotic duration. The measure will be calculated using electronic health record (EHR) data and is intended for use at the facility level for both quality improvement and pay-for-performance.

Measure Specs
General Information
1.7 Measure Type
1.7 Composite Measure
No
1.3 Electronic Clinical Quality Measure (eCQM)
1.8 Level of Analysis
1.10 Measure Rationale

The overall objective of this electronic clinical quality measure is to quantify excess antibiotic duration in hospitalized adults with uncomplicated community-acquired pneumonia (CAP).

Antibiotic overuse is a national and international public health emergency with antibiotic resistant infections estimated to directly cause 1.27 million deaths globally and indirectly contribute to 4.95 million deaths.1 National studies by the Centers for Disease Control and Prevention (CDC) estimate that up to 50% of hospitalized patients receive antibiotic therapy, most commonly for pneumonia, and that up to 40% of antibiotic prescribing could be improved.2 Because of these harms, the CDC developed recommendations for Antibiotic Stewardship which it published in its “Core Elements of Hospital Antibiotic Stewardship Programs.”3 These recommendations include “Assessing how often patients are discharged on the correct antibiotics for the recommended duration.” Specifically, the CDC recommends, “most cases of uncomplicated pneumonia can be treated for 5 days when a patient has a timely clinical response.”3 The 5-day treatment duration is based on national 5-day guideline recommendations for uncomplicated CAP, multiple randomized clinical trials showing the safety of short vs. long durations,4-14 and retrospective observational studies showing higher antibiotic-associated adverse events in patients who receive excess antibiotic durations.15

 

Pneumonia is not only the most common reason for inpatient antibiotic use but also the most common infectious cause of mortality in the US resulting in approximately 1.4 million emergency department visits, 740 000 hospitalizations, 41 000 deaths, and $7.7 billion in inpatient costs each year in the US.16-19 Given studies suggesting that up to ⅔ of patients hospitalized and treated for CAP have excess duration,15,20 there is substantial potential benefit to patients and the US by reducing excess treatment durations. For patients, shorter durations are associated with fewer antibiotic-associated adverse events and less risk of developing antibiotic resistant infections.15,21-23  When used as a pay-for-performance measure across 41 Michigan hospitals, the chart review measure from which our eCQM was adapted increased appropriate use of short duration therapy for CAP by 22% and decreased adverse events (driven by antibiotic-associated harm; adjusted Odds Ratio (aOR) per quarter, 0.98 [95% confidence interval: .96-.99]).24 Taken together, our guideline-based measure has the demonstrated ability to improve patient care for a large number of patients hospitalized with CAP across the US.

 

How will this measure improve quality of care? By establishing a standardized process for assessing treatment duration for CAP, a larger proportion of patients will receive appropriate care that is consistent with the 2019 ATS/IDSA CAP national guidelines.25 Appropriateness of antibiotic therapy for pneumonia is a priority for numerous federal and accreditation organizations–including the CDC, The Joint Commission, and Centers for Medicare and Medicaid Services–and is not currently captured in typical quality improvement measures. For example, National Healthcare Safety Network (NHSN) antimicrobial use (AU) module focuses on quantifying antibiotic use and comparing it to expected values, with no assessment of appropriateness or duration of therapy. Notably, the NHSN AU initiative could be augmented with an eCQM to assess appropriateness of antibiotic duration for CAP, the most common indication for inpatient antibiotic use.

 

What are the benefits or improvements in quality envisioned by this measure? Duration of antibiotic therapy for CAP often exceeds national guidelines. Michigan Hospital Medicine Safety Consortium and CDC data analyses report excessive duration of antibiotics for >70% of CAP cases in the US.15,20 The consequences of excess duration of therapy include adverse events in 20% of patients who receive unnecessary antibiotics, with increasing risk for each excess day of therapy for pneumonia.15 Conversely, a quality initiative (based on a chart review version of this measure) to adhere to 5-day antibiotic duration in CAP patients implemented across 41 hospitals was associated with a higher percentage of appropriate duration and fewer adverse events.24 

 

The full reference list can be found in Section 2.2

1.20 Types of Data Sources
1.25 Data Source Details

 

The anticipated data source for the measure is electronic health record (EHR) data from inpatient hospital admissions, including discharge diagnosis codes, pharmacy and medication administration, and imaging records. These data are all collected routinely during usual clinical care through the process of inpatient hospitalizations.